Loading...
The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma
In the past two decades, there has been a significant improvement in the understanding of the molecular pathogenesis of Renal Cell Carcinoma (RCC). These insights in the biological pathways have resulted in the development of multiple agents targeting vascular endothelial growth factor (VEGF), as we...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7017064/ https://ncbi.nlm.nih.gov/pubmed/31936065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010143 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|